Stocks and Investing Stocks and Investing
Thu, June 29, 2023

Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $6 on, Jun 29th, 2023


Published on 2024-10-28 04:34:38 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $6 on, Jun 29th, 2023.

Gil has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 1 agrees with Gil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Lapides of "Morgan Stanley" Maintained at Hold with Decreased Target to $1 on, Thursday, March 30th, 2023


These are the ratings of the 4 analyists that currently disagree with Gil


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $2 on, Monday, May 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $2 on, Thursday, March 30th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, March 30th, 2023
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, March 30th, 2023
Contributing Sources